STRATA CRITICAL MEDICAL, INC. Stock-Based Compensation
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Stock-Based Compensation of $8.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.71M, a 30.72% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $5.04M, a 19.40% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $6.59M, a 45.51% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.68M, a 68.90% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $17.83M, a 10.36% decline from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $19.89M, a 59.13% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $12.50M, a 51.03% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $8.28M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.74M 10-Q · filed 2026-08-04 | $15.33M derived: sum of 3 quarters · filed 2026-08-04 | $17.01M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.04M 10-Q · filed 2026-05-06 | $11.62M derived: sum of 2 quarters · filed 2026-05-06 | $13.30M derived: sum of 3 quarters · filed 2026-05-06 | $18.65M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $8.27M derived: sum of 2 quarters · filed 2026-03-03 | $13.62M derived: sum of 3 quarters · filed 2026-08-04 | $17.83M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.03M derived: sum of 2 quarters · filed 2026-08-04 | $11.25M 10-Q · filed 2025-11-10 | $15.77M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.57M 10-Q · filed 2026-08-04 | $14.09M derived: sum of 3 quarters · filed 2026-08-04 | $19.49M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.22M 10-Q · filed 2026-05-06 | $8.74M derived: sum of 2 quarters · filed 2026-05-06 | $14.14M derived: sum of 3 quarters · filed 2026-05-06 | $19.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.93M derived: sum of 2 quarters · filed 2026-03-03 | $15.57M derived: sum of 3 quarters · filed 2026-03-03 | $19.89M 10-K · filed 2026-03-03 |
| 2024-09-30 | $5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $11.05M derived: sum of 2 quarters · filed 2025-11-10 | $15.37M 10-Q · filed 2025-11-10 | $18.52M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $9.96M 10-Q · filed 2025-08-05 | $13.12M derived: sum of 3 quarters · filed 2025-08-05 | $16.45M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $4.32M 10-Q · filed 2025-05-12 | $7.47M derived: sum of 2 quarters · filed 2025-05-12 | $10.80M derived: sum of 3 quarters · filed 2025-05-12 | $13.60M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $6.48M derived: sum of 2 quarters · filed 2025-03-13 | $9.28M derived: sum of 3 quarters · filed 2025-03-13 | $12.50M 10-K · filed 2025-03-13 |
| 2023-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $6.13M derived: sum of 2 quarters · filed 2024-11-12 | $9.35M 10-Q · filed 2024-11-12 | $12.00M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.02M 10-Q · filed 2024-08-08 | $8.67M derived: sum of 3 quarters · filed 2024-08-08 | $10.35M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $3.22M 10-Q · filed 2024-05-07 | $5.87M derived: sum of 2 quarters · filed 2024-05-07 | $7.56M derived: sum of 3 quarters · filed 2024-05-07 | $9.40M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $4.33M derived: sum of 2 quarters · filed 2024-03-12 | $6.18M derived: sum of 3 quarters · filed 2024-03-12 | $8.28M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.53M derived: sum of 2 quarters · filed 2023-11-08 | $5.63M 10-Q · filed 2023-11-08 | $8.56M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.94M 10-Q · filed 2023-08-09 | $6.87M derived: sum of 3 quarters · filed 2023-08-09 | $10.80M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.10M 10-Q · filed 2023-05-11 | $5.03M derived: sum of 2 quarters · filed 2023-05-11 | $8.95M derived: sum of 3 quarters · filed 2023-05-11 | $11.47M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.93M 10-K · filed 2023-03-16 | $6.86M derived: sum of 2 quarters · filed 2023-03-16 | $9.37M derived: sum of 3 quarters · filed 2023-03-16 | $11.28M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-09-30 | $3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $6.44M derived: sum of 2 quarters · filed 2022-11-10 | $8.35M 10-Q · filed 2022-11-10 | $9.62M 10-K · filed 2023-03-16 |
| 2021-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.42M 10-Q · filed 2022-08-09 | $5.70M derived: sum of 3 quarters · filed 2023-01-10 | |
| 2021-03-31 | $1.90M 10-Q · filed 2022-05-10 | $3.18M derived: sum of 2 quarters · filed 2023-01-10 | ||
| 2020-12-31 | $1.27M 8-K · filed 2023-01-10 | |||
| 2020-09-30 | $490.00K 10-K · filed 2021-12-20 | |||
| 2019-09-30 | $317.00K 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |